Medical Microbiology
A section of Microorganisms (ISSN 2076-2607).
Section Information
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Latest Review Papers in Medical Microbiology 2024 (Deadline: 30 September 2024)
- Staphylococcus aureus: Host Interactions and Adaptation (Deadline: 30 September 2024)
- Borreliosis and Other Tick-Borne Diseases in the Northern and Southern Hemispheres (Deadline: 30 September 2024)
- Prevention and Treatment of Healthcare-Associated Infections (Deadline: 30 September 2024)
- New Trends in Medical Bacteriology: Diagnosis, Treatment and Prevention (Deadline: 30 September 2024)
- Pneumonia: New Diagnostic and Therapeutic Options (Deadline: 30 September 2024)
- State-of-the-Art Medical Microbiology in the USA (2023, 2024) (Deadline: 30 September 2024)
- Oral Microbes and Human Health (Deadline: 30 September 2024)
- Advances in Medical Microbiology (Deadline: 30 September 2024)
- Human Skin Microbiota, 2nd Edition (Deadline: 30 September 2024)
- The One Health Challenge: Zoonotic Parasites (Deadline: 30 September 2024)
- Colonization and Virulence of Opportunistic Pathogens (Deadline: 30 September 2024)
- Exploring Microbial Dynamics in Oral Health and Disease: Periodontics, Implant Dentistry and Endodontics (Deadline: 30 September 2024)
- Advancements in Pathogenic Bacteria: Detection, Genomic Analysis, and Antibiotic Resistance (Deadline: 30 September 2024)
- Parasitic Diseases in Humans and Animals (Deadline: 30 September 2024)
- Understanding the Interactions between HIV and Other Infections and Their Impact on Immune Function (Deadline: 30 September 2024)
- New Obstacles in Bacterial, Fungal and Viral Infections: Antimicrobial Resistance and Emerging Pathogens (Deadline: 30 September 2024)
- Emerging Pathogens in the Context of One Health (Deadline: 30 September 2024)
- Oral Microbiota and Candidiasis (Deadline: 30 September 2024)
- Shiga-Toxin Producing Escherichia coli and the Animal Host (Deadline: 30 September 2024)
- Microbial Infections during Pregnancy: Second Edition (Deadline: 15 October 2024)
- Effects of Respiratory Viral Infections on the Nervous System (Deadline: 15 October 2024)
- Anti-inflammatory Property of Probiotics (Deadline: 15 October 2024)
- Current Developments in Urogenital Infections (Deadline: 30 October 2024)
- Microbial Interactions including Candida concerning Health and Disease (Deadline: 31 October 2024)
- Molecular Techniques, Novel Biomarkers and Coagulation-Based Methods in the Diagnosis of Periprosthetic Joint Infections (Deadline: 31 October 2024)
- Virulence and Resistance of Klebsiella pneumoniae, 2nd Edition (Deadline: 31 October 2024)
- Bacteria Control by Phages (Deadline: 31 October 2024)
- Leaky Skin Syndrome (Deadline: 31 October 2024)
- Genomics and Epidemiology of Clinical Microorganisms (Deadline: 31 October 2024)
- Latest Research on Clostridioides difficile (Deadline: 31 October 2024)
- Chlamydiae and Chlamydia-Like Infections (Deadline: 31 October 2024)
- Healthcare-Associated Infections and Antimicrobial Therapy (Deadline: 31 October 2024)
- Sepsis: Underlying Mechanisms, Pathogen-Host Interactions, Precision Diagnostic, Therapeutic Approaches, and Supportive Management (Deadline: 31 October 2024)
- Prevention and Treatment of Helicobacter pylori Infection Related Gastrointestinal Disease (Deadline: 31 October 2024)
- Tick-Borne Diseases and Zoonotic Diseases (Deadline: 15 November 2024)
- Advances in Brucella (Deadline: 15 November 2024)
- Emerging Pathogens Causing Acute Hepatitis (Deadline: 15 November 2024)
- Mycobacterium abscessus: Current Knowledgement on an Emerging Pathogen (Deadline: 15 November 2024)
- Gene Expression Profiling in Leishmania: From Basic Research to Vaccines and Drug Targets (Deadline: 15 November 2024)
- Advances in Cutaneous Mycosis (Deadline: 15 November 2024)
- Virus-Driven Skin Diseases (Deadline: 15 November 2024)
- Overview of Healthcare-Associated Infections (Deadline: 30 November 2024)
- Detection and Analysis of Clinical Microbial Infections, Second Edition (Deadline: 30 November 2024)
- Pseudomonas aeruginosa: Pathogenicity, Drug Resistance Mechanisms and Interaction with the Host (Deadline: 30 November 2024)
- Advances in Mycoplasma Research (Deadline: 30 November 2024)
- Mycobacterial Tuberculosis Pathogenesis and Vaccine Development (Deadline: 30 November 2024)
- Recent Advances in Clostridioides difficile Infection (Deadline: 30 November 2024)
- Novel Approaches in the Diagnosis and Control of Emerging Pathogens (Deadline: 30 November 2024)
- Bacteremia and Sepsis (Deadline: 30 November 2024)
- Invasive Fungal Infections: Immunomodulation and Molecular Biology (Deadline: 30 November 2024)
- Advances in Cryptococcus and Cryptococcosis, 2nd Edition (Deadline: 30 November 2024)
- Research on Relevant Clinical Infections (Deadline: 15 December 2024)
- Microbiota in Human Health and Disease (Deadline: 15 December 2024)
- State-of-the-Art Medical Microbiology in UK (2023, 2024) (Deadline: 15 December 2024)
- The Central Role of Microbiota in Eye Health (Deadline: 15 December 2024)
- Biology and Pathogenesis of Staphylococcus Infection (2nd Edition) (Deadline: 15 December 2024)
- State-of-the-Art Medical Microbiology in Italy (2023, 2024) (Deadline: 15 December 2024)
- Hepatitis B Virus Infection and Vaccine (Deadline: 15 December 2024)
- Bacterial Infections in Clinical Settings (Deadline: 15 December 2024)
- Research on Leishmania and Leishmaniasis (Deadline: 15 December 2024)
- Epidemiology and Pathogenesis of Human Enteroviruses: 2nd Edition (Deadline: 20 December 2024)
- Drug Resistance and Molecular Research of Staphylococcus spp. (Deadline: 31 December 2024)
- Rare Human Pathogens (Deadline: 31 December 2024)
- Infections in Solid Organ Transplant Recipients (Deadline: 31 December 2024)
- Current Pattern in Epidemiology and Antifungal Resistance (Deadline: 31 December 2024)
- Method and Model Development Supporting Vaccines and Therapeutics against Viral and Bacterial Pathogens and Toxins (Deadline: 31 December 2024)
- Microbial Infections and Rheumatic Diseases (Deadline: 31 December 2024)
- Pathogen Infections and Respiratory Diseases (Deadline: 31 December 2024)
- Sexually Transmitted Infections and Human Immunodeficiency Virus: Co-infections, Co-morbidities, Preclinical Development and Treatment (Deadline: 31 December 2024)
- Stem-Cell Based 3D Organoids; Application in Microbial Pathogenesis and Advances (Deadline: 31 December 2024)
- The Vaginal Microbiome in Health and Disease (Deadline: 31 December 2024)
- Ocular Microorganisms (Deadline: 15 January 2025)
- Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) for the Identification of Pathogenic Microorganisms, 3rd Edition (Deadline: 15 January 2025)
- Helicobacter pylori Infection: Detection and Novel Treatment (Deadline: 15 January 2025)
- Advances in Phage Therapies (Deadline: 15 January 2025)
- The Human Microbiome and Its Impact on Rheumatic and Neurological Diseases (Deadline: 31 January 2025)
- Discovering the Human Holobiont: How the Microbiome Affects Human Health (Deadline: 31 January 2025)
- COVID-19 Diagnostics in Clinical Applications, Long-Term Effect and Pandemic Controls (Deadline: 31 January 2025)
- The Infective Endocarditis (Deadline: 31 January 2025)
- The Microbiome of the Urinary Tract: A Balance between Eubiosis and Dysbiosis (Deadline: 15 February 2025)
- Editorial Board Members’ Collection Series: Bacterial Infection (Deadline: 15 February 2025)
- Pathogenesis and Host Response Modulation by Porphyromonas gingivalis (Deadline: 28 February 2025)